• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
WAN Yue,LI Meng.Patent overview of PI3Kδ inhibitors for the treatment of cancer[J].Journal Of Pharmaceutical Research,2020,39(7):430-434[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2543times   Download 2937次 QR Code for this article
Scan with your phone!
基于癌症治疗的PI3Kδ抑制剂的专利技术综述
万玥,李萌
Font:Larger+|Default|Smaller-
(国家知识产权局专利局专利审查协作天津中心,天津 300304)
摘要:
磷酸肌醇-3-激酶δ(PI3Kδ)作为重要的磷酸肌醇-3-激酶类型,主要在白细胞中表达,在B细胞的增殖、分化、成熟等过程中扮演重要角色,并且是血液系统恶性肿瘤和自身免疫性疾病如类风湿性关节炎治疗过程中的重要靶点。本文已磷酸肌醇-3-激酶δ抑制剂2015—2019年间相关的专利申请文献为基础,对其在专利中的结构分类进行统计分析,为相关技术研发人员提供参考。
关键词:  磷酸肌醇-3-激酶δ  抑制剂  结构分类
DOI:10.13506/j.cnki.jpr.2020.07.015
基金项目:
Patent overview of PI3Kδ inhibitors for the treatment of cancer
WAN Yue,LI Meng
(Patent Examination Cooperation Center of the Patent Office, SIPO,Tianjin 300304,China)
Abstract:
PI3Kδ is an important subtype of PI3K kinases, which is mainly expressed in leukocytes and plays an important role in the proliferation, differentiation, maturation and self-reaction of B cells. It is an effective target in the treatment of hematological malignancies and autoimmune diseases such as rheumatoid arthritis. Based on the patent application literatures dating 2015—2019 related to PI3Kδ inhibitors, this paper analyzes its structural types in patents, providing supports for related researchers.
Key words:  PI3Kδ inhibitors structural types
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.